Saturday, January 13, 2024

The Use of Paxlovid For COVID-19

 


The anti-viral drug Paxlovid is available for use. There are tight controls of the medication. The intent of its creation was to help people with severe COVID-19. Some patients may have extreme reactions to particular vaccines and a pill could be a solution. The debate comes with what was stated previously. The vaccines produced were safe and effective, so Paxlovid is unnecessary. Booster shots exist for fighting new variants. Pfizer has been producing mRNA vaccines to fight COVID-19. If the mRNA technology is truly effective, Paxlovid  would not be needed. The only time for such a drug would be in emergency situations. Paxlovid is two drugs which contains nimatreviler and ritonavir. The complication comes with individuals on multiple medications. All of them are going to interact in the body. A patient would have to tell their doctor of  all the medications they take. They would then have to determine a way to avoid  harmful effects from the interactions between medications. The recommendation for Paxlovid is that anyone 12 and up can be given the drug. Those who are 50 or with comorbidities can be given Paxlovid. What Pfizer appears to be doing is putting a product out on the market for the sake of profit. No reports of adverse effects have appeared. Considering Pfizer did not test their vaccines for transmission, distrust from the public remains. A person who was vaccinated could still spread the virus. The CDC reported that COVID-19 deaths spiked in December of 2023. This was not due to the lack of medications or treatment. The healthcare system is on the verge of collapse. Medicine price remains too high for a population with stagnant wages. Pharmaceutical corporations need more regulation to prevent unethical business practices. The long term effects of Paxlovid are not known. The fact the drug got FDA approval demonstrates that it is pharmaceutical  corporations dictating public health policy. 

No comments:

Post a Comment